Denali Therapeutics Inc. (DNLI) Deferred Tax Assets, Valuation Allowance USD 2017 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Denali Therapeutics Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2017 to 2023.
  • Denali Therapeutics Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $376 M, a 13% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $376 M +$43.2 M +13% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $333 M +$104 M +45.5% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $229 M +$95.5 M +71.8% Dec 31, 2021 10-K 2023-02-27
Q4 2020 $133 M +$20.3 M +18% Dec 31, 2020 10-K 2022-02-28
Q4 2019 $113 M +$51.8 M +85% Dec 31, 2019 10-K 2021-02-26
Q4 2018 $60.9 M +$6.27 M +11.5% Dec 31, 2018 10-K 2020-02-27
Q4 2017 $54.7 M Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.